JIUN-KAE JACK LEE to Angiogenesis Inhibitors
This is a "connection" page, showing publications JIUN-KAE JACK LEE has written about Angiogenesis Inhibitors.
Connection Strength
0.080
-
Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol. 2010 Jan 10; 28(2):193-201.
Score: 0.051
-
P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy. Oncotarget. 2013 May; 4(5):705-14.
Score: 0.016
-
Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial. J Natl Cancer Inst. 2010 Jun 16; 102(12):859-65.
Score: 0.013